Edgewise Therapeutics, Inc. (EWTX) Misses Q4 EPS by 4c

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) reported Q4 EPS of ($0.47), $0.04 worse than the analyst estimate of ($0.43).

For earnings history and earnings-related data on Edgewise Therapeutics, Inc. (EWTX) click here.

You May Also Be Interested In

• Edgewise Therapeutics (EWTX) PT Raised to $59; RBC Capital: 'We would be buyers on weakness'
• Playboy to buy back 16.6M shares from Fortress at $1.05 each
• Ennis (EBF) Reports In-Line Q1 EPS